| Authors: |
Chemais M; Department of Clinical Biology, Centre Hospitalier Régional de la Haute Senne, Belgium; European Society of Clinical Microbiology and Infectious Diseases Vaccines Study Group (EVASG), Basel, Switzerland. Electronic address: monia.chemais@chrhautesenne.be., MacDonald N; Department of Paediatrics (Infectious Diseases), Dalhousie University and Izaak Walton Killam Health Centre, Halifax Nova Scotia Canada, Canada., Dubé E; Department of Anthropology, Laval University, Québec, Québec City, Canada., Søborg B; Department of Infectious Disease Epidemiology and Prevention, Statens Serum Institut, Copenhagen, Denmark., Cevik M; Division of Infection and Global Health Research, School of Medicine, University of St Andrews, United Kingdom., Harboe ZB; Department of Respiratory and Infectious Diseases, Copenhagen University Hospital, North Zealand, Copenhagen, Denmark; Department of Bacteria, Parasites and Fungi, Statens Serum Institut, Copenhagen, Denmark; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark; European Society of Clinical Microbiology and Infectious Diseases Vaccines Study Group (EVASG), Basel, Switzerland., Velikov P; Department of Infectious Diseases, Parasitology and Tropical Medicine, Medical University of Sofia, Bulgaria; European Society of Clinical Microbiology and Infectious Diseases Vaccines Study Group (EVASG), Basel, Switzerland. |
